The first landmark randomised prospective trial published in this field, SALTIRE,17 demonstrated that high-dose atorvastatin does not slow the progression of this disease.

• 第一个划时代的随机预期试验在这个领域发表，SALTIRE证明高剂量阿托伐他汀不能减慢这种疾病的进程。